Comparing cancer care in the United States and Europe reveals significant differences in method . The US system, often characterized as insurance-based, tends to focus cutting-edge advancements, frequently resulting in greater costs and unequal access for care. Conversely, many European countries operate under publicly funded healthcare models, whi